Renal Dialysis (Hemodialysis)

Subscribe to Selected New Research on Renal Dialysis

17769 relevant articles (717 outcomes, 1806 trials/studies) found for this Therapy

Description: Therapy for the insufficient cleansing of the BLOOD by the kidneys based on dialysis and including hemodialysis, PERITONEAL DIALYSIS, and HEMODIAFILTRATION.

Also Known As:

Hemodialysis; Dialysis, Renal; Dialyses, Extracorporeal; Dialyses, Renal; Extracorporeal Dialyses; Hemodialyses; Renal Dialyses; Dialysis, Extracorporeal; Extracorporeal Dialysis

Relationship Network

Therapy Context: Research Results

Therapeutics: 5192

Renal Replacement Therapy: 1723

Renal Dialysis: 17769

Peritoneal Dialysis: 4813

Home Hemodialysis: 67

Hemodiafiltration

Sorption Detoxification: 26

Renal Dialysis: 17769

Peritoneal Dialysis: 4813

Home Hemodialysis: 67

Hemodiafiltration

Experts

1.	Sezer, Siren: 14 articles (07/2008 - 01/2002)
2.	Haberal, Mehmet: 13 articles (07/2008 - 01/2002)
3.	Akiba, Takashi: 13 articles (05/2008 - 01/2002)
4.	Kuzminskis, Vytautas: 11 articles (01/2007 - 01/2003)
5.	Nasri, Hamid: 10 articles (07/2008 - 01/2004)
6.	Eleftheriadis, Theodoros: 10 articles (04/2008 - 01/2005)
7.	Chan, Christopher T: 10 articles (12/2006 - 06/2002)
8.	Chen, Jin-Bor: 10 articles (12/2005 - 07/2002)
9.	Akizawa, Tadao: 9 articles (09/2008 - 04/2002)
10.	Allon, Michael: 9 articles (05/2008 - 03/2002)

Related Diseases

1.	Chronic Kidney Failure (Chronic Renal Failure) 01/01/1996 - "Increasing use of medications designed specifically for intravenous administration during hemodialysis has dramatically improved the treatment of many comorbid conditions accompanying end-stage renal disease" 06/01/1978 - "The records of 272 recipients of cadaver allografts and of 650 dialyzed patients (440 center dialysis and 210 home dialysis) were reviewed in an attempt to determine whether hemodialysis or transplantation is the best treatment for end-stage renal failure" 01/01/2007 - "High Body Mass Index (BMI) has been associated with improved survival of End-Stage Renal Disease (ESRD) patients on chronic hemodialysis (HD); however, studies on the relationship of BMI with survival in Peritoneal Dialysis (PD) patients have yielded conflicting results" 07/01/2006 - "Although hemodialysis (HD) has improved the life expectancy of patients with end-stage renal disease (ESRD), uremic patients continue to experience high morbidity and mortality" 10/01/2001 - "After 2 years' follow-up, seven mothers achieved complete remission, three had died, three developed chronic renal failure (CRF), and two progressed to end stage renal failure (ESRF) requiring chronic hemodialysis" Get all the results and reference details, order at left...
2.	Anemia 07/01/1983 - "Previous report on improvement in anemia most likely reflected the smaller loss of blood during CAPD compared with hemodialysis." 04/01/2007 - "CONCLUSION: This clinical study showed that Espogen has proven effective and safe for treatment of anemia in hemodialysis patients" 02/01/1989 - "It is concluded that r-huEPO is very effective in treating the anemia of patients maintained on hemodialysis" 05/01/1997 - "Our study suggests that improvement of anemia in patients on long-term hemodialysis by administration of EPO is associated with an improvement in hearing capacity in a significant number of patients" 02/01/1993 - "Anemia contributes to significant debilitation in hemodialysis patients and, when reversed with epoetin therapy, results in significantly improved muscle function and endurance." Get all the results and reference details, order at left...
3.	Kidney Failure (Renal Failure) 06/01/1995 - "Seventeen (53%) patients attained a complete remission and 22 (69%) survived (five in advanced renal failure and long-term hemodialysis)" 08/01/1992 - "The accumulation of this E-21 IA in renal failure is evidence that the kidney has a major role in the clearance of this fragment, which is not accomplished by the membranes used in hemodialysis." 04/01/2003 - "Depolymerized holothurian glycosaminoglycan (DHG), a novel alternative anticoagulant for hemodialysis, is safe and effective in a dog renal failure model." 03/01/2004 - "BACKGROUND AND AIM OF THE STUDY: The safety and efficacy of beating-heart valve surgery as a myocardial protection strategy was evaluated in patients with renal failure requiring hemodialysis" 09/01/2008 - "Remission was achieved in 17 (85%) cases; one required hemodialysis and 2 died due to renal failure and central nervous system involvement" Get all the results and reference details, order at left...
4.	Infection 07/01/1987 - "Most catheter or shunt infections in hemodialysis patients require the removal of the access before the infection is eradicated" 02/01/2005 - "Only in patients on hemodialysis or chronic ambulatory peritoneal dialysis (CAPD) was a significant reduction of the infection rate found" 01/01/2004 - "The hope offered for improved outcomes in this patient population should be tempered by realistic expectations for device performance especially in patients with significant morbidities, poor vasculature, a history of poorly performing hemodialysis catheters, or multiple catheter-related infections" 01/01/1992 - "The high rate of infection of hemodialysis patients with hepatitis C virus in our setting points to the need for improved control measures." 07/01/2007 - "CONCLUSION: Long-term central venous accesses using tunneled internal jugular catheters appeared to be safe and effective for both hemodialysis and long-term infusion therapies, with relatively higher infection rates in oncologic patients." Get all the results and reference details, order at left...
5.	Secondary Hyperparathyroidism 07/01/2005 - "Here we present a hemodialysis patient with severe secondary hyperparathyroidism who was found to have abnormally higher plasma bio-intact-PTH concentrations than intact-PTH concentrations, and the abnormally high biointact-PTH/intact-PTH ratio improved after parathyroidectomy (PTx)" 06/01/1993 - "The patients in Group I responded well to hemodialysis and drug therapy, but those in Group II were likely to have secondary hyperparathyroidism" 01/01/1984 - "The radiological and histological appearances of secondary hyperparathyroidism improved or seemed to worsen to a lesser degree in CAPD compared to hemodialysis patients." 05/01/2008 - "STUDY AIMS: To survey bone mineral disturbances in the hemodialysis (HD) population in Europe and current clinical practice in Europe for the prevention, diagnosis and treatment of secondary hyperparathyroidism (SHPT) in HD patients" 11/01/2006 - "AIM: The purpose of the study was to examine the effect of hemodiafiltration with endogenous reinfusion (HFR) compared to hemodialysis (HD) on 28 uremic patients with secondary hyperparathyroidism (2HPT) but positively selected for good and stable control of phosphatemia in order to evaluate the independent effects of dialysis treatments on bone turnover metabolism" Get all the results and reference details, order at left...
1166 Diseases and 17769 more articles analyzed in the Research Interface, order at left...

Related Drugs and Biologics

1.	Erythropoietin
2.	Calcitriol (Calcijex)
3.	Iron (Serum Iron Level)
4.	Heparin (Liquaemin)
5.	Calcium
6.	Creatinine
7.	hydroxide ion
8.	Carnitine (L-Carnitine)
9.	Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight)
10.	Phosphorus (Red Phosphorus)
1699 Drugs and Important Bio-Agents and 6193 more articles analyzed in the Research Interface, order at left...

Related Therapies and Procedures

1.	Transplants (Transplant)
2.	Peritoneal Dialysis
3.	Continuous Ambulatory Peritoneal Dialysis (CAPD)
4.	Hemoperfusion
5.	Kidney Transplantation
206 Therapies and Procedures and 3345 more articles analyzed in the Research Interface, order at left...

Research Interface

Rapidly retrieve summaries of all the evidence for any disease in seconds. Save hours of search and analysis time. CureHunter is unlike any "search engine" you have ever used. Where standard "search engines" produce lists of links, CureHunter quantifies evidence, extracts it from the literature and calculates a result you can use to immediately facilitate evidence based decision making in Real Clinical Time.

Unlimited Disease, Drug and Therapy Search
2 clicks from Disease to Drug to Evidence
Trial References
All the Positive Outcomes
Detailed Relationship Timeline Charts
Full Article Reference Details
Includes Mobile Interface Subscription
One-click to FDA Products/Patents
Request Institution License details >>

Price:

$490.00 access via web interface, 1 year subscription

Proceed to Checkout >>

Mobile Interface

Retrieve summaries of all the evidence for any disease from your Mobile Phone or PDA. Accelerate decision making in the field. Speed up your study of new drug and disease domains. Refresh your knowledge on the road.

Access from any web enabled PDA or Phone
Trial references
All the Positive Outcomes
Drug and Therapy searches
Full Article Reference Details
Try Mobile Interface >>

Price:

$45.00 access via "curehunter.com/m", 1 year subscription

Proceed to Checkout >>